Spots Global Cancer Trial Database for hepatic
Every month we try and update this database with for hepatic cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors | NCT02605083 | Cancer | eFT508 | 18 Years - | Effector Therapeutics | |
| Endoscopic Ultrasound Guided Liver Biopsy | NCT03307811 | Hepatic Cancer Hepatic Neoplas... Hepatic Carcino... | 22 gauge needle... | 19 Years - | AdventHealth | |
| Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization | NCT00434109 | Neuroendocrine ... Islet Cell Tumo... | Sunitinib malat... Hepatic Artery ... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver | NCT02885753 | Colorectal Neop... | Oxaliplatin int... 5 FU bolus Folinic acid Oxaliplatin int... Panitumumab Bevacizumab 5 FU continuous Irinotecan | 18 Years - | Federation Francophone de Cancerologie Digestive | |
| A Study of Axitinib in Advanced Carcinoid Tumors | NCT01435122 | Carcinoid Tumor | Axitinib | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Study of Axitinib in Advanced Carcinoid Tumors | NCT01435122 | Carcinoid Tumor | Axitinib | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Wet Heparinized Suction for Abdominal Cancer | NCT05041335 | Cancer of Pancr... Cancer of Stoma... Cancer of Esoph... Cancer of Liver Cancer | wet heparinzed ... Microsieve No heparin flus... No microsieve | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Study to Assess PV-10 Chemoablation of Cancer of the Liver | NCT00986661 | Cancer Metastat... Hepatocellular ... Metastatic Mela... Metastatic Ocul... Metastatic Uvea... Metastatic Lung... Metastatic Colo... Metastatic Colo... Metastatic Brea... Metastatic Panc... | PV-10 (10% rose... | 18 Years - | Provectus Pharmaceuticals | |
| A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic Impairment | NCT02301104 | Advanced Solid ... | TAS-102 | 18 Years - | Taiho Oncology, Inc. | |
| The Effect of Fish Oils on Human Hepatic Colorectal Metastases | NCT00942292 | Colorectal Live... | Lipidem- fish o... Digital Contras... | 18 Years - 80 Years | University Hospitals, Leicester | |
| A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors | NCT02605083 | Cancer | eFT508 | 18 Years - | Effector Therapeutics | |
| Everolimus After (Chemo)Embolization for Liver Metastases From Digestive Endocrine Tumors | NCT01678664 | Neuroendocrine ... Hepatic Metasta... Metastases | Everolimus embolization Doxorubicin | 18 Years - | Federation Francophone de Cancerologie Digestive | |
| A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy | NCT00587067 | Hepatic Cancer | FLOXURIDINE | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic Impairment | NCT02301104 | Advanced Solid ... | TAS-102 | 18 Years - | Taiho Oncology, Inc. | |
| Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases | NCT00327652 | Neoplasm Metast... Liver Neoplasms Carcinoma | CRS-100 | 18 Years - | Anza Therapeutics, Inc. | |
| A Study to Assess PV-10 Chemoablation of Cancer of the Liver | NCT00986661 | Cancer Metastat... Hepatocellular ... Metastatic Mela... Metastatic Ocul... Metastatic Uvea... Metastatic Lung... Metastatic Colo... Metastatic Colo... Metastatic Brea... Metastatic Panc... | PV-10 (10% rose... | 18 Years - | Provectus Pharmaceuticals | |
| A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy | NCT00587067 | Hepatic Cancer | FLOXURIDINE | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy | NCT00587067 | Hepatic Cancer | FLOXURIDINE | 18 Years - | Memorial Sloan Kettering Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
